Suppr超能文献

肥胖、高胰岛素血症、糖尿病与阿尔茨海默病:流行病学视角

Adiposity, hyperinsulinemia, diabetes and Alzheimer's disease: an epidemiological perspective.

作者信息

Luchsinger José Alejandro

机构信息

Taub Institute for Research of Alzheimer's Disease and the Aging Brain, Columbia University, New York, NY, USA.

出版信息

Eur J Pharmacol. 2008 May 6;585(1):119-29. doi: 10.1016/j.ejphar.2008.02.048. Epub 2008 Mar 4.

Abstract

The objective of this manuscript is to provide a comprehensive review of the epidemiologic evidence linking the continuum of adiposity, hyperinsulinemia, and diabetes with Alzheimer's disease. The mechanisms for these associations remain to be elucidated, but may include direct actions from insulin, advanced products of glycosilation, cerebrovascular disease, and products of adipose tissue metabolism. Elevated adiposity in middle age is related to a higher risk of Alzheimer's disease. The evidence relating adiposity in old age to Alzheimer's disease is conflicting. Several studies have shown that hyperinsulinemia, a consequence of higher adiposity and insulin resistance, is also related to a higher risk of Alzheimer's disease. Hyperinsulinemia is a risk factor for diabetes, and numerous studies have shown a relation of diabetes with higher Alzheimer's disease risk. Most studies fail the take into account the continuum linking these risk factors which may result in underestimation of their importance in Alzheimer's disease. The implication of these associations is that a large proportion of the world population may be at increased risk of Alzheimer's disease given the trends for increasing prevalence of overweight, obesity, hyperinsulinemia, and diabetes. However, if proven causal, these associations also present a unique opportunity for prevention and treatment of Alzheimer's disease.

摘要

本手稿的目的是全面综述将肥胖、高胰岛素血症和糖尿病的连续体与阿尔茨海默病联系起来的流行病学证据。这些关联的机制仍有待阐明,但可能包括胰岛素的直接作用、糖基化终末产物、脑血管疾病以及脂肪组织代谢产物。中年时期肥胖程度升高与患阿尔茨海默病的风险较高有关。老年时期肥胖与阿尔茨海默病之间的关系证据相互矛盾。多项研究表明,高胰岛素血症作为肥胖程度较高和胰岛素抵抗的结果,也与患阿尔茨海默病的风险较高有关。高胰岛素血症是糖尿病的一个风险因素,并且大量研究已表明糖尿病与较高的阿尔茨海默病风险之间存在关联。大多数研究未能考虑到这些风险因素之间的连续体,这可能导致低估它们在阿尔茨海默病中的重要性。这些关联的意义在于,鉴于超重、肥胖、高胰岛素血症和糖尿病患病率上升的趋势,世界上很大一部分人口可能患阿尔茨海默病的风险增加。然而,如果这些关联被证明具有因果关系,它们也为阿尔茨海默病的预防和治疗提供了一个独特的机会。

相似文献

1
Adiposity, hyperinsulinemia, diabetes and Alzheimer's disease: an epidemiological perspective.
Eur J Pharmacol. 2008 May 6;585(1):119-29. doi: 10.1016/j.ejphar.2008.02.048. Epub 2008 Mar 4.
2
Adiposity, type 2 diabetes, and Alzheimer's disease.
J Alzheimers Dis. 2009;16(4):693-704. doi: 10.3233/JAD-2009-1022.
3
Type 2 diabetes, related conditions, in relation and dementia: an opportunity for prevention?
J Alzheimers Dis. 2010;20(3):723-36. doi: 10.3233/JAD-2010-091687.
4
Adiposity and Alzheimer's disease.
Curr Opin Clin Nutr Metab Care. 2009 Jan;12(1):15-21. doi: 10.1097/MCO.0b013e32831c8c71.
5
Adiposity and Alzheimer's disease.
Curr Alzheimer Res. 2007 Apr;4(2):127-34. doi: 10.2174/156720507780362100.
6
Cardiovascular risk factors and Alzheimer's disease.
Curr Atheroscler Rep. 2004 Jul;6(4):261-6. doi: 10.1007/s11883-004-0056-z.
7
Diabetes, related conditions, and dementia.
J Neurol Sci. 2010 Dec 15;299(1-2):35-8. doi: 10.1016/j.jns.2010.08.063.
8
Link between type 2 diabetes and Alzheimer's disease: from epidemiology to mechanism and treatment.
Clin Interv Aging. 2015 Mar 10;10:549-60. doi: 10.2147/CIA.S74042. eCollection 2015.
9
Hyperinsulinemia or Insulin Resistance: What Impacts the Progression of Alzheimer's Disease?
J Alzheimers Dis. 2019;72(s1):S71-S79. doi: 10.3233/JAD-190808.
10
Hyperinsulinemia, insulin resistance and colorectal adenomas: A meta-analysis.
Metabolism. 2015 Oct;64(10):1324-33. doi: 10.1016/j.metabol.2015.06.013. Epub 2015 Jun 20.

引用本文的文献

1
Drugs repurposing in the experimental models of Alzheimer's disease.
Inflammopharmacology. 2025 Jan;33(1):195-214. doi: 10.1007/s10787-024-01608-7. Epub 2025 Jan 3.
2
The role of PI3K signaling pathway in Alzheimer's disease.
Front Aging Neurosci. 2024 Sep 27;16:1459025. doi: 10.3389/fnagi.2024.1459025. eCollection 2024.
3
Association between pre-diabetes or diabetes and cognitive impairment in a community-dwelling older population: Bushehr Elderly Health (BEH) program.
J Diabetes Metab Disord. 2023 Oct 18;23(1):639-646. doi: 10.1007/s40200-023-01325-y. eCollection 2024 Jun.
6
Alzheimer's Disease: Treatment Strategies and Their Limitations.
Int J Mol Sci. 2022 Nov 12;23(22):13954. doi: 10.3390/ijms232213954.
7
Novel molecular mechanisms in Alzheimer's disease: The potential role of DEK in disease pathogenesis.
Front Aging Neurosci. 2022 Oct 6;14:1018180. doi: 10.3389/fnagi.2022.1018180. eCollection 2022.
8
Artichoke Leaf Extract-Mediated Neuroprotection against Effects of Aflatoxin in Male Rats.
Biomed Res Int. 2022 Jul 19;2022:4421828. doi: 10.1155/2022/4421828. eCollection 2022.
9
Androgen deprivation therapy and risk of cognitive dysfunction in men with prostate cancer: is there a possible link?
Prostate Int. 2022 Mar;10(1):68-74. doi: 10.1016/j.prnil.2021.02.002. Epub 2021 Mar 9.
10
Consideration of sex and gender in Alzheimer's disease and related disorders from a global perspective.
Alzheimers Dement. 2022 Dec;18(12):2707-2724. doi: 10.1002/alz.12662. Epub 2022 Apr 8.

本文引用的文献

1
Metabolic syndrome and dementia risk in a multiethnic elderly cohort.
Dement Geriatr Cogn Disord. 2007;24(3):185-92. doi: 10.1159/000105927. Epub 2007 Jul 18.
2
Rosiglitazone and cardiotoxicity--weighing the evidence.
N Engl J Med. 2007 Jul 5;357(1):64-6. doi: 10.1056/NEJMe078117. Epub 2007 Jun 5.
3
Relation of diabetes to mild cognitive impairment.
Arch Neurol. 2007 Apr;64(4):570-5. doi: 10.1001/archneur.64.4.570.
4
Trials that matter: rosiglitazone, ramipril, and the prevention of type 2 diabetes.
Ann Intern Med. 2007 Mar 20;146(6):461-3. doi: 10.7326/0003-4819-146-6-200703200-00015.
5
Measures of adiposity and dementia risk in elderly persons.
Arch Neurol. 2007 Mar;64(3):392-8. doi: 10.1001/archneur.64.3.392.
6
Association of metabolic syndrome with Alzheimer disease: a population-based study.
Neurology. 2006 Sep 12;67(5):843-7. doi: 10.1212/01.wnl.0000234037.91185.99.
7
A work in progress: the metabolic syndrome.
Sci Aging Knowledge Environ. 2006 Jun 28;2006(10):pe19. doi: 10.1126/sageke.2006.10.pe19.
8
Cachexia: pathophysiology and clinical relevance.
Am J Clin Nutr. 2006 Apr;83(4):735-43. doi: 10.1093/ajcn/83.4.735.
10
Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer's disease.
Pharmacogenomics J. 2006 Jul-Aug;6(4):246-54. doi: 10.1038/sj.tpj.6500369. Epub 2006 Jan 31.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验